首页 > 市场调查报告书 > 製药

神经疾病

市场调查报告书

商品编码

1672049

全球肌萎缩侧索硬化症治疗市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Amyotrophic Lateral Sclerosis Treatment Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 111 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球肌萎缩侧索硬化症治疗市场规模预计将从 2024 年的 7.6204 亿美元增长到 2033 年的 11.9849 亿美元，在 2026 年至 2033 年的预测期内呈现 5.16% 的强劲年复合成长率(CAGR)。

肌萎缩侧索硬化症 (ALS) 治疗市场正在经历显着增长，这得益于这种神经退化性疾病的盛行率不断上升以及治疗方案的进步。 ALS 的特征是运动神经元的进行性退化，由于其复杂的病理生理学，在治疗中带来了独特的挑战。然而，利鲁唑和依达拉奉等疾病改良疗法的最新发展已显示出减缓疾病进展和改善患者预后的前景。正在进行的新治疗方法的研究，包括基因治疗和干细胞治疗，正在进一步扩大 ALS 管理的前景。

此外，人们对 ALS 的认识不断提高以及专门研究计划的建立正在推动对有效治疗方案的需求。倡导团体和组织在提高意识和资助研究方面发挥着至关重要的作用，从而增加了对 ALS 治疗的投资。此外，由于临床医生试图根据个别患者的概况和遗传因素来制定干预措施，个人化医疗的关注正在影响 ALS 治疗市场。这种方法旨在提高治疗效果并满足每位患者的独特需求。

此外，多学科护理模式的整合正在改变 ALS 的管理。神经科医生、物理治疗师、职业治疗师和营养师之间的协作方法对于提供全面的护理以解决 ALS 患者面临的各种挑战至关重要。这种整体方法不仅可以提高生活质量，还可以在整个疾病过程中为患者及其家人提供支持。总之，ALS 治疗市场将实现强劲增长，其特点是创新、认识的提高以及致力于改善这一充满挑战的治疗领域的患者护理。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

报告涵盖的细分

透过药物

利鲁唑
依达拉奉
其他的

按类型

散发性 ALS
家族性 ALS

按配销通路

医院药房
线上提供者
药局和零售药局
公司简介
阿尔肯实验室有限公司
Aquestive Therapeutics 公司
义大利法玛科公司
Viatris 公司
三菱化学集团公司
Amylyx 製药公司
大冢製药株式会社
格兰马克製药有限公司
Covis Pharma GmbH
太阳製药工业有限公司
以上清单可以自订。

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 9 章：肌萎缩侧索硬化症治疗公司的竞争格局

肌萎缩侧索硬化症治疗市场竞争
伙伴关係/合作/协议
合併与收购
新产品发布
其他进展

第十章：公司简介

顶级公司市占率分析
市场集中度
Alkem Laboratories Ltd

公司概况
公司收入
产品
最新动态

Aquestive Therapeutics Inc.

公司概况
公司收入
产品
最新动态

Italfarmaco SPA

公司概况
公司收入
产品
最新动态

Viatris Inc.

公司概况
公司收入
产品
最新动态

Mitsubishi Chemical Group Corporation

公司概况
公司收入
产品
最新动态

Amylyx Pharmaceuticals Inc.

公司概况
公司收入
产品
最新动态

Otsuka Pharmaceutical Co. Ltd.

公司概况
公司收入
产品
最新动态

Glenmark Pharmaceuticals Limited

公司概况
公司收入
产品
最新动态

Covis Pharma GmbH

公司概况
公司收入
产品
最新动态

Sun Pharmaceutical Industries Ltd

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR11216729

Global Amyotrophic Lateral Sclerosis Treatment Market size is anticipated to grow from USD 762.04 Million in 2024 to USD 1198.49 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.16% during the forecast period of 2026 to 2033.

The amyotrophic lateral sclerosis (ALS) treatment market is witnessing significant growth, driven by the increasing prevalence of this neurodegenerative disease and advancements in therapeutic options. ALS, characterized by the progressive degeneration of motor neurons, presents unique challenges in treatment due to its complex pathophysiology. However, recent developments in disease-modifying therapies, such as riluzole and edaravone, have shown promise in slowing disease progression and improving patient outcomes. Ongoing research into novel therapeutic approaches, including gene therapy and stem cell treatments, is further expanding the landscape of ALS management.

Moreover, the growing awareness of ALS and the establishment of dedicated research initiatives are propelling the demand for effective treatment options. Advocacy groups and organizations are playing a crucial role in raising awareness and funding research, leading to increased investment in ALS therapies. Additionally, the focus on personalized medicine is influencing the ALS treatment market, as clinicians seek to tailor interventions based on individual patient profiles and genetic factors. This approach aims to enhance treatment efficacy and address the unique needs of each patient.

Furthermore, the integration of multidisciplinary care models is transforming the management of ALS. Collaborative approaches involving neurologists, physical therapists, occupational therapists, and nutritionists are essential for providing comprehensive care that addresses the diverse challenges faced by ALS patients. This holistic approach not only improves quality of life but also supports patients and their families throughout the disease journey. In conclusion, the ALS treatment market is set for robust growth, characterized by innovation, increased awareness, and a commitment to improving patient care in this challenging therapeutic area.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Drugs

Riluzole
Edaravone
Others

By Type

Sporadic ALS
Familial ALS

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AMYOTROPHIC LATERAL SCLEROSIS TREATMENT INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drugs
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY DRUGS

5.1. Overview By Drugs
5.2. Historical and Forecast Data Analysis By Drugs
5.3. Riluzole Historic and Forecast Sales By Regions
5.4. Edaravone Historic and Forecast Sales By Regions
5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data Analysis By Type
6.3. Sporadic ALS Historic and Forecast Sales By Regions
6.4. Familial ALS Historic and Forecast Sales By Regions

7. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1. Overview By Distribution Channel
7.2. Historical and Forecast Data Analysis By Distribution Channel
7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
7.4. Online Providers Historic and Forecast Sales By Regions
7.5. Drug Stores and Retail Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT COMPANIES

9.1. Amyotrophic Lateral Sclerosis Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF AMYOTROPHIC LATERAL SCLEROSIS TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Alkem Laboratories Ltd
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Aquestive Therapeutics Inc.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Italfarmaco S.P.A.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Viatris Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Mitsubishi Chemical Group Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Amylyx Pharmaceuticals Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Otsuka Pharmaceutical Co. Ltd.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Glenmark Pharmaceuticals Limited
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Covis Pharma GmbH
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Sun Pharmaceutical Industries Ltd
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Drugs (USD MN)
Riluzole Market Sales By Geography (USD MN)
Edaravone Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Type (USD MN)
Sporadic ALS Market Sales By Geography (USD MN)
Familial ALS Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacies Market Sales By Geography (USD MN)
Online Providers Market Sales By Geography (USD MN)
Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
Global Amyotrophic Lateral Sclerosis Treatment Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Amyotrophic Lateral Sclerosis Treatment Report
Market Research Process
Market Research Methodology
Global Amyotrophic Lateral Sclerosis Treatment Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Drugs
Market Attractiveness Analysis By Type
Market Attractiveness Analysis By Distribution Channel
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Drugs (USD MN)
Riluzole Market Sales By Geography (USD MN)
Edaravone Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Type (USD MN)
Sporadic ALS Market Sales By Geography (USD MN)
Familial ALS Market Sales By Geography (USD MN)
Global Market Analysis By Distribution Channel (USD MN)
Hospital Pharmacies Market Sales By Geography (USD MN)
Online Providers Market Sales By Geography (USD MN)
Drug Stores and Retail Pharmacies Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.